The Serum and Glucocorticoid-regulated Kinase 1 in Hypoxic Renal Injury
Overview
Cell Biology
Pharmacology
Authors
Affiliations
The serum- and glucocorticoid-inducible kinase 1 (SGK1) is a serine threonine protein kinase activated through the phosphatidylinositol 3-kinase (PI3-kinase) pathway and counteracting apoptosis. Protein expression and activation of SGK1 are increased in various models of cell stress. The present study explored the role of SGK1 in renal hypoxia/ischemia induced apoptosis. HEK 293 cells were exposed in vitro to hypoxia/reoxygenation (H/R), which increased SGK1 transcript levels, SGK1 protein abundance and SGK1 phosphorylation. H/R injury further enhanced the percentage of apoptotic cells, an effect significantly blunted by prior SGK1 overexpression. In vivo renal ischemia/reperfusion (I/R) injury increased SGK1 transcript levels and SGK1 protein abundance. I/R enhanced apoptosis, an effect significantly more pronounced in gene targeted mice lacking SGK1. In conclusion, SGK1 is up-regulated and counteracts apoptosis following H/R in vitro and ischemia In vivo.
Ueda N Int J Mol Sci. 2022; 23(7).
PMID: 35409370 PMC: 9000186. DOI: 10.3390/ijms23074010.
Packialakshmi B, Stewart I, Burmeister D, Feng Y, McDaniel D, Chung K Physiol Rep. 2022; 10(3):e15181.
PMID: 35146957 PMC: 8831939. DOI: 10.14814/phy2.15181.
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy.
Guerriero I, Monaco G, Coppola V, Orlacchio A Pharmaceuticals (Basel). 2020; 13(11).
PMID: 33266470 PMC: 7700219. DOI: 10.3390/ph13110413.
Spencer S, Wheeler-Jones C, Elliott J J Vet Pharmacol Ther. 2020; 43(3):243-267.
PMID: 32128854 PMC: 8614124. DOI: 10.1111/jvp.12848.
Xie Y, Jiang D, Xiao J, Fu C, Zhang Z, Ye Z Cell Death Dis. 2018; 9(3):338.
PMID: 29497029 PMC: 5832808. DOI: 10.1038/s41419-018-0358-7.